Market Research Logo

Global Asthma Therapeutics Market Analysis 2016 - Forecast to 2022

Global Asthma Therapeutics Market Analysis 2016 - Forecast to 2022

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Asthma Therapeutics". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:

  • Market Sizing estimations and forecasts for a minimum of 6 years of all the given segments, sub segments and the regional markets
  • Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Regional and country level market analysis
  • Competitive landscaping mapping the key common trends
  • Company profiling covering the financials, recent activities and the future strategies
  • Supply chain trends mapping the recent advancements
  • Strategic recommendations for the new entrants


1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations
2 Executive Summary
3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Asthma Therapeutics Market by Route of Administration
5.1 Introduction
5.2 Parenteral
5.3 Inhalation
5.4 Oral
6 Asthma Therapeutics Market by Drug Class
6.1 Introduction
6.2 Bronchodilators
6.3 Mast cell stabilizers
6.4 Anti-inflammatory
6.5 Immunosuppressants
6.6 Combination therapies
6.7 Leukotriene antagonists
7 Asthma Therapeutics Market by Product
7.1 Introduction
7.2 Nebulizers
7.3 Inhalers
7.3.1 Soft mist inhalers
7.3.2 Dry powder inhalers
7.3.3 Metered dose inhalers
8 Geographical Segmentation
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 RoW
8.4.1 Latin America
8.4.2 Middle East
8.4.3 Africa
8.4.4 Others
9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiles
10.1 Roche Diagnostics
10.1.1 Business Overview
10.1.2 SWOT Analysis
10.1.3 Financial Overview
10.1.4 Strategy
10.1.5 Key Activities
10.2 Sanofi-Aventis SA
10.3 AstraZeneca
10.4 Merck& Co., Inc.
10.5 CareFusion Corporation
10.6 Boehringer Ingelheim
10.7 Teva Pharmaceutical Industries Ltd.
10.8 Sunovion Pharmaceuticals, Inc.
10.9 F. Hoffmann-La Roche
10.10 Philips Healthcare
10.11 GSK
10.12 GlaxoSmithKline Plc
10.13 Mitsubishi Tanabe Pharma Corporation
10.14 Pearl Therapeutics
10.15 Pulmagen Therapeutics
10.16 Dynavax Technologies Corp.
10.17 Array BioPharma
10.18 SAMA Pharmaceuticals
10.19 Sterna Biologicals
10.20 Regeneron Pharmaceuticals
11 Appendix
12 Disclaimer
List of Tables
Table 1 Global Asthma Therapeutics Market Analysis, by Region, 2013-2022 ($MN)
Table 2 Global Asthma Therapeutics Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 3 Global Parenteral Market Analysis, by Region, 2013-2022 ($MN)
Table 4 Global Parenteral Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 5 Global Parenteral Market Analysis, by Product, 2013-2022 ($MN)
Table 6 Global Inhalation Market Analysis, by Region, 2013-2022 ($MN)
Table 7 Global Inhalation Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 8 Global Inhalation Market Analysis, by Product, 2013-2022 ($MN)
Table 9 Global Oral Market Analysis, by Region, 2013-2022 ($MN)
Table 10 Global Oral Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 11 Global Oral Market Analysis, by Product, 2013-2022 ($MN)
Table 12 Global Asthma Therapeutics Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 13 Global Bronchodilators Market Analysis, by Region, 2013-2022 ($MN)
Table 14 Global Bronchodilators Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 15 Global Bronchodilators Market Analysis, by Product, 2013-2022 ($MN)
Table 16 Global Mast cell stabilizers Market Analysis, by Region, 2013-2022 ($MN)
Table 17 Global Mast cell stabilizers Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 18 Global Mast cell stabilizers Market Analysis, by Product, 2013-2022 ($MN)
Table 19 Global Anti-inflammatory Market Analysis, by Region, 2013-2022 ($MN)
Table 20 Global Anti-inflammatory Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 21 Global Anti-inflammatory Market Analysis, by Product, 2013-2022 ($MN)
Table 22 Global Immunosuppressants Market Analysis, by Region, 2013-2022 ($MN)
Table 23 Global Immunosuppressants Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 24 Global Immunosuppressants Market Analysis, by Product, 2013-2022 ($MN)
Table 25 Global Combination therapies Market Analysis, by Region, 2013-2022 ($MN)
Table 26 Global Combination therapies Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 27 Global Combination therapies Market Analysis, by Product, 2013-2022 ($MN)
Table 28 Global Leukotriene antagonists Market Analysis, by Region, 2013-2022 ($MN)
Table 29 Global Leukotriene antagonists Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 30 Global Leukotriene antagonists Market Analysis, by Product, 2013-2022 ($MN)
Table 31 Global Asthma Therapeutics Market Analysis, by Product, 2013-2022 ($MN)
Table 32 Global Nebulizers Market Analysis, by Region, 2013-2022 ($MN)
Table 33 Global Nebulizers Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 34 Global Nebulizers Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 35 Global Inhalers Market Analysis, by Region, 2013-2022 ($MN)
Table 36 Global Inhalers Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 37 Global Inhalers Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 38 North America Asthma Therapeutics Market Analysis, by Country, 2013-2022 ($MN)
Table 39 North America Asthma Therapeutics Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 40 North America Parenteral Market Analysis, by Country, 2013-2022 ($MN)
Table 41 North America Parenteral Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 42 North America Parenteral Market Analysis, by Product, 2013-2022 ($MN)
Table 43 North America Inhalation Market Analysis, by Country, 2013-2022 ($MN)
Table 44 North America Inhalation Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 45 North America Inhalation Market Analysis, by Product, 2013-2022 ($MN)
Table 46 North America Oral Market Analysis, by Country, 2013-2022 ($MN)
Table 47 North America Oral Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 48 North America Oral Market Analysis, by Product, 2013-2022 ($MN)
Table 49 North America Asthma Therapeutics Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 50 North America Bronchodilators Market Analysis, by Country, 2013-2022 ($MN)
Table 51 North America Bronchodilators Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 52 North America Bronchodilators Market Analysis, by Product, 2013-2022 ($MN)
Table 53 North America Mast cell stabilizers Market Analysis, by Country, 2013-2022 ($MN)
Table 54 North America Mast cell stabilizers Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 55 North America Mast cell stabilizers Market Analysis, by Product, 2013-2022 ($MN)
Table 56 North America Anti-inflammatory Market Analysis, by Country, 2013-2022 ($MN)
Table 57 North America Anti-inflammatory Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 58 North America Anti-inflammatory Market Analysis, by Product, 2013-2022 ($MN)
Table 59 North America Immunosuppressants Market Analysis, by Country, 2013-2022 ($MN)
Table 60 North America Immunosuppressants Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 61 North America Immunosuppressants Market Analysis, by Product, 2013-2022 ($MN)
Table 62 North America Combination therapies Market Analysis, by Country, 2013-2022 ($MN)
Table 63 North America Combination therapies Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 64 North America Combination therapies Market Analysis, by Product, 2013-2022 ($MN)
Table 65 North America Leukotriene antagonists Market Analysis, by Country, 2013-2022 ($MN)
Table 66 North America Leukotriene antagonists Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 67 North America Leukotriene antagonists Market Analysis, by Product, 2013-2022 ($MN)
Table 68 North America Asthma Therapeutics Market Analysis, by Product, 2013-2022 ($MN)
Table 69 North America Nebulizers Market Analysis, by Country, 2013-2022 ($MN)
Table 70 North America Nebulizers Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 71 North America Nebulizers Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 72 North America Inhalers Market Analysis, by Country, 2013-2022 ($MN)
Table 73 North America Inhalers Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 74 North America Inhalers Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 75 Europe Asthma Therapeutics Market Analysis, by Country, 2013-2022 ($MN)
Table 76 Europe Asthma Therapeutics Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 77 Europe Parenteral Market Analysis, by Country, 2013-2022 ($MN)
Table 78 Europe Parenteral Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 79 Europe Parenteral Market Analysis, by Product, 2013-2022 ($MN)
Table 80 Europe Inhalation Market Analysis, by Country, 2013-2022 ($MN)
Table 81 Europe Inhalation Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 82 Europe Inhalation Market Analysis, by Product, 2013-2022 ($MN)
Table 83 Europe Oral Market Analysis, by Country, 2013-2022 ($MN)
Table 84 Europe Oral Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 85 Europe Oral Market Analysis, by Product, 2013-2022 ($MN)
Table 86 Europe Asthma Therapeutics Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 87 Europe Bronchodilators Market Analysis, by Country, 2013-2022 ($MN)
Table 88 Europe Bronchodilators Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 89 Europe Bronchodilators Market Analysis, by Product, 2013-2022 ($MN)
Table 90 Europe Mast cell stabilizers Market Analysis, by Country, 2013-2022 ($MN)
Table 91 Europe Mast cell stabilizers Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 92 Europe Mast cell stabilizers Market Analysis, by Product, 2013-2022 ($MN)
Table 93 Europe Anti-inflammatory Market Analysis, by Country, 2013-2022 ($MN)
Table 94 Europe Anti-inflammatory Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 95 Europe Anti-inflammatory Market Analysis, by Product, 2013-2022 ($MN)
Table 96 Europe Immunosuppressants Market Analysis, by Country, 2013-2022 ($MN)
Table 97 Europe Immunosuppressants Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 98 Europe Immunosuppressants Market Analysis, by Product, 2013-2022 ($MN)
Table 99 Europe Combination therapies Market Analysis, by Country, 2013-2022 ($MN)
Table 100 Europe Combination therapies Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 101 Europe Combination therapies Market Analysis, by Product, 2013-2022 ($MN)
Table 102 Europe Leukotriene antagonists Market Analysis, by Country, 2013-2022 ($MN)
Table 103 Europe Leukotriene antagonists Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 104 Europe Leukotriene antagonists Market Analysis, by Product, 2013-2022 ($MN)
Table 105 Europe Asthma Therapeutics Market Analysis, by Product, 2013-2022 ($MN)
Table 106 Europe Nebulizers Market Analysis, by Country, 2013-2022 ($MN)
Table 107 Europe Nebulizers Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 108 Europe Nebulizers Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 109 Europe Inhalers Market Analysis, by Country, 2013-2022 ($MN)
Table 110 Europe Inhalers Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 111 Europe Inhalers Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 112 Asia Pacific Asthma Therapeutics Market Analysis, by Country, 2013-2022 ($MN)
Table 113 Asia Pacific Asthma Therapeutics Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 114 Asia Pacific Parenteral Market Analysis, by Country, 2013-2022 ($MN)
Table 115 Asia Pacific Parenteral Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 116 Asia Pacific Parenteral Market Analysis, by Product, 2013-2022 ($MN)
Table 117 Asia Pacific Inhalation Market Analysis, by Country, 2013-2022 ($MN)
Table 118 Asia Pacific Inhalation Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 119 Asia Pacific Inhalation Market Analysis, by Product, 2013-2022 ($MN)
Table 120 Asia Pacific Oral Market Analysis, by Country, 2013-2022 ($MN)
Table 121 Asia Pacific Oral Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 122 Asia Pacific Oral Market Analysis, by Product, 2013-2022 ($MN)
Table 123 Asia Pacific Asthma Therapeutics Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 124 Asia Pacific Bronchodilators Market Analysis, by Country, 2013-2022 ($MN)
Table 125 Asia Pacific Bronchodilators Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 126 Asia Pacific Bronchodilators Market Analysis, by Product, 2013-2022 ($MN)
Table 127 Asia Pacific Mast cell stabilizers Market Analysis, by Country, 2013-2022 ($MN)
Table 128 Asia Pacific Mast cell stabilizers Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 129 Asia Pacific Mast cell stabilizers Market Analysis, by Product, 2013-2022 ($MN)
Table 130 Asia Pacific Anti-inflammatory Market Analysis, by Country, 2013-2022 ($MN)
Table 131 Asia Pacific Anti-inflammatory Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 132 Asia Pacific Anti-inflammatory Market Analysis, by Product, 2013-2022 ($MN)
Table 133 Asia Pacific Immunosuppressants Market Analysis, by Country, 2013-2022 ($MN)
Table 134 Asia Pacific Immunosuppressants Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 135 Asia Pacific Immunosuppressants Market Analysis, by Product, 2013-2022 ($MN)
Table 136 Asia Pacific Combination therapies Market Analysis, by Country, 2013-2022 ($MN)
Table 137 Asia Pacific Combination therapies Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 138 Asia Pacific Combination therapies Market Analysis, by Product, 2013-2022 ($MN)
Table 139 Asia Pacific Leukotriene antagonists Market Analysis, by Country, 2013-2022 ($MN)
Table 140 Asia Pacific Leukotriene antagonists Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 141 Asia Pacific Leukotriene antagonists Market Analysis, by Product, 2013-2022 ($MN)
Table 142 Asia Pacific Asthma Therapeutics Market Analysis, by Product, 2013-2022 ($MN)
Table 143 Asia Pacific Nebulizers Market Analysis, by Country, 2013-2022 ($MN)
Table 144 Asia Pacific Nebulizers Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 145 Asia Pacific Nebulizers Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 146 Asia Pacific Inhalers Market Analysis, by Country, 2013-2022 ($MN)
Table 147 Asia Pacific Inhalers Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 148 Asia Pacific Inhalers Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 149 RoW Asthma Therapeutics Market Analysis, by Country, 2013-2022 ($MN)
Table 150 RoW Asthma Therapeutics Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 151 RoW Parenteral Market Analysis, by Country, 2013-2022 ($MN)
Table 152 RoW Parenteral Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 153 RoW Parenteral Market Analysis, by Product, 2013-2022 ($MN)
Table 154 RoW Inhalation Market Analysis, by Country, 2013-2022 ($MN)
Table 155 RoW Inhalation Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 156 RoW Inhalation Market Analysis, by Product, 2013-2022 ($MN)
Table 157 RoW Oral Market Analysis, by Country, 2013-2022 ($MN)
Table 158 RoW Oral Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 159 RoW Oral Market Analysis, by Product, 2013-2022 ($MN)
Table 160 RoW Asthma Therapeutics Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 161 RoW Bronchodilators Market Analysis, by Country, 2013-2022 ($MN)
Table 162 RoW Bronchodilators Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 163 RoW Bronchodilators Market Analysis, by Product, 2013-2022 ($MN)
Table 164 RoW Mast cell stabilizers Market Analysis, by Country, 2013-2022 ($MN)
Table 165 RoW Mast cell stabilizers Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 166 RoW Mast cell stabilizers Market Analysis, by Product, 2013-2022 ($MN)
Table 167 RoW Anti-inflammatory Market Analysis, by Country, 2013-2022 ($MN)
Table 168 RoW Anti-inflammatory Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 169 RoW Anti-inflammatory Market Analysis, by Product, 2013-2022 ($MN)
Table 170 RoW Immunosuppressants Market Analysis, by Country, 2013-2022 ($MN)
Table 171 RoW Immunosuppressants Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 172 RoW Immunosuppressants Market Analysis, by Product, 2013-2022 ($MN)
Table 173 RoW Combination therapies Market Analysis, by Country, 2013-2022 ($MN)
Table 174 RoW Combination therapies Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 175 RoW Combination therapies Market Analysis, by Product, 2013-2022 ($MN)
Table 176 RoW Leukotriene antagonists Market Analysis, by Country, 2013-2022 ($MN)
Table 177 RoW Leukotriene antagonists Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 178 RoW Leukotriene antagonists Market Analysis, by Product, 2013-2022 ($MN)
Table 179 RoW Asthma Therapeutics Market Analysis, by Product, 2013-2022 ($MN)
Table 180 RoW Nebulizers Market Analysis, by Country, 2013-2022 ($MN)
Table 181 RoW Nebulizers Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 182 RoW Nebulizers Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 183 RoW Inhalers Market Analysis, by Country, 2013-2022 ($MN)
Table 184 RoW Inhalers Market Analysis, by Route of Administration, 2013-2022 ($MN)
Table 185 RoW Inhalers Market Analysis, by Drug Class, 2013-2022 ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report